secwatch.observer — SEC 8-K summary
======================================

Issuer:     SRx Health Solutions, Inc. (SRXH)
CIK:        0001471727
Form:       8-K
Filed at:   2023-08-22T23:59:59+00:00
Accession:  0001628280-23-030190
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Better Choice Q2 net revenue $10.5M; gross margin up 543 bps YoY to 34%
-----------------------------------------------------------------------

- Net revenue of $10.5M, down 36% YoY but up 14% from Q1 2023.
- Gross margin improved 543 bps YoY to 34%; operating loss improved 39% to $(2.6)M.
- Net loss improved 32% to $(3.0)M; EPS improved 33% YoY to $(0.10).
- Appointed Kent Cunningham as CEO; strategic partnership with Alphia for dry kibble manufacturing.
- Paid down $13.5M revolving credit line; supply chain constraints expected to resolve by end of Q3.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1471727/000162828023030190/0001628280-23-030190-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1471727/000162828023030190/bttr-20230821.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-030190

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer